ME Therapeutics Holdings (METX) Stock Price Prediction from 2024 to 2045 (Complete Information)

ME Therapeutics Holdings is a biotechnology based company which is currently focusing on the development of drugs that boost the body’s own immune system to defeat cancer – and they are calling it the next generation of “therapeutics targeting immune suppression”.

ME Therapeutics Holdings was listed on the Canadian Securities Exchange on October 12, 2023. In the duration span of less than a year, the share price of the company has increased more than 2500%. Given the fact that the company’s share price has seen an amazing growth in this short duration, should you invest in ME Therapeutics Holdings? Your all queries will be cleared when you read this article on ME Therapeutics Holdings (METX) Stock Price Prediction from 2024 – 2045.

ME Therapeutics Holdings (METX) Stock Price Prediction

Table of Contents

Company’s current and upcoming goals:

The company is working on a new area of cancer research called Immuno Oncology. In recent times, the company has made strategic collaboration with another biotechnology company called NanoVation Therapeutics and has started clinical trials directly on the human body.

Another area that ME Therapeutics Holdings is focusing on is to target myeloid cells. Myeloid cells are a kind of immune cell whose function is to protect the body from infections – just like other immune cells do. However, these types of cells have another function which restricts the human body from killing the tumor cells. ME Therapeutics Holdings is developing a way by which the body will be able to restrict the particular function of the myeloid cells so that these cells don’t restrict the body from killing the tumor cells.

ME Therapeutics Holdings (METX) Stock Price Prediction 2024 – 2045

ME Therapeutics Holdings (METX) Stock Price PredictionPrediction Price
ME Therapeutics Holdings (METX) Stock Price Prediction 20241.22
ME Therapeutics Holdings (METX) Stock Price Prediction 20251.235
ME Therapeutics Holdings (METX) Stock Price Prediction 20261.337
ME Therapeutics Holdings (METX) Stock Price Prediction 20271.448
ME Therapeutics Holdings (METX) Stock Price Prediction 20281.568
ME Therapeutics Holdings (METX) Stock Price Prediction 20291.698
ME Therapeutics Holdings (METX) Stock Price Prediction 20301.839
ME Therapeutics Holdings (METX) Stock Price Prediction 20352.740
ME Therapeutics Holdings (METX) Stock Price Prediction 20404.083
ME Therapeutics Holdings (METX) Stock Price Prediction 20456.083

ME Therapeutics Holdings (METX) Stock Price Prediction 2024

The average price of the stock of ME Therapeutics Holdings (METX) for 2025 will be CAD 1.191, with a high forecast of CAD 1.235, and a lower forecast of CAD 1.148.

MonthShare price in CAD
January1.20
February1.17
March4.40
April3.45
May3.99
June4.94
July4.91
August3.50
September1.50
October1.41
November1.35
December1.22

ME Therapeutics Holdings (METX) Stock Price Prediction 2025

The average price of the stock of ME Therapeutics Holdings (METX) for 2025 will be CAD 1.191, with a high forecast of CAD 1.235, and a lower forecast of CAD 1.148.

MonthShare price in CAD
January1.148
February1.155
March1.163
April1.171
May1.179
June1.186
July1.194
August1.202
September1.210
October1.218
November1.226
December1.235

ME Therapeutics Holdings (METX) Stock Price Prediction 2026

The average price of the stock of ME Therapeutics Holdings (METX) for 2026 will be CAD 1.289, with a high forecast of CAD 1.337, and a lower forecast of CAD 1.243.

MonthShare price in CAD
January1.243
February1.251
March1.259
April1.268
May1.276
June1.285
July1.293
August1.302
September1.311
October1.319
November1.328
December1.337

Suggested: Scottie Resources (SCOT) Stock Price Prediction from 2024 to 2045

ME Therapeutics Holdings (METX) Stock Price Prediction 2027

The average price of the stock of ME Therapeutics Holdings (METX) for 2027 will be CAD 1.396, with a high forecast of CAD 1.448, and a lower forecast of CAD 1.346.

MonthShare price in CAD
January1.346
February1.355
March1.364
April1.373
May1.382
June1.391
July1.401
August1.410
September1.419
October1.429
November1.438
December1.448

ME Therapeutics Holdings (METX) Stock Price Prediction 2028

The average price of the stock of ME Therapeutics Holdings (METX) for 2028 will be CAD 1.512, with a high forecast of CAD 1.568, and a lower forecast of CAD 1.458.

MonthShare price in CAD
January1.458
February1.467
March1.477
April1.487
May1.497
June1.507
July1.517
August1.527
September1.537
October1.548
November1.558
December1.568

ME Therapeutics Holdings (METX) Stock Price Prediction 2029

The average price of the stock of ME Therapeutics Holdings (METX) for 2029 will be CAD 1.638, with a high forecast of CAD 1.698, and a lower forecast of CAD 1.579.

MonthShare price in CAD
January1.579
February1.589
March1.600
April1.611
May1.621
June1.632
July1.643
August1.654
September1.665
October1.676
November1.687
December1.698

ME Therapeutics Holdings (METX) Stock Price Prediction 2030

The average price of the stock of ME Therapeutics Holdings (METX) for 2030 will be CAD 1.774, with a high forecast of CAD 1.839, and a lower forecast of CAD 1.710.

MonthShare price in CAD
January1.710
February1.721
March1.733
April1.744
May1.756
June1.768
July1.779
August1.791
September1.803
October1.815
November1.827
December1.839

ME Therapeutics Holdings (METX) Stock Price Prediction 2035

The average price of the stock of ME Therapeutics Holdings (METX) for 2035 will be CAD 2.643, with a high forecast of CAD 2.740, and a lower forecast of CAD 2.547.

MonthShare price in CAD
January2.547
February2.564
March2.581
April2.599
May2.616
June2.633
July2.651
August2.669
September2.686
October2.704
November2.722
December2.740

ME Therapeutics Holdings (METX) Stock Price Prediction 2040

The average price of the stock of ME Therapeutics Holdings (METX) for 2040 will be CAD 3.937, with a high forecast of CAD 4.083, and a lower forecast of CAD 3.795.

MonthShare price in CAD
January3.795
February3.820
March3.846
April3.871
May3.897
June3.923
July3.949
August3.976
September4.002
October4.029
November4.056
December4.083

ME Therapeutics Holdings (METX) Stock Price Prediction 2045

The average price of the stock of ME Therapeutics Holdings (METX) for 2045 will be CAD 5.866, with a high forecast of CAD 6.083, and a lower forecast of CAD 5.654.

MonthShare price in CAD
January5.654
February5.692
March5.730
April5.768
May5.806
June5.845
July5.884
August5.923
September5.963
October6.002
November6.043
December6.083

ME Therapeutics Holdings (METX) Stock Price – Historical Pricing

ME Therapeutics Holdings (METX) Stock Price in 2023 & 2024

ME Therapeutics Holdings (METX) Historical PricingOpening PriceClosing Price
ME Therapeutics Holdings (METX) Stock Price in November 20230.050 CAD0.50 CAD
ME Therapeutics Holdings (METX) Stock Price in December 20230.120 CAD1.20 CAD
ME Therapeutics Holdings (METX) Stock Price in January 20241.20 CAD1.13 CAD
ME Therapeutics Holdings (METX) Stock Price in February 20244.40 CAD4.40 CAD
ME Therapeutics Holdings (METX) Stock Price in March 20243.45 CAD3.41 CAD
ME Therapeutics Holdings (METX) Stock Price in April 20243.99 CAD3.96 CAD
ME Therapeutics Holdings (METX) Stock Price in May 20244.94 CAD4.94 CAD
ME Therapeutics Holdings (METX) Stock Price in June 20244.91 CAD3.71 CAD
ME Therapeutics Holdings (METX) Stock Price in July 20243.50 CAD4.00 CAD
ME Therapeutics Holdings (METX) Stock Price in August 20241.50 CAD2.75 CAD

ME Therapeutics Holdings (METX) Stock Price in November 2023

In November 2023, the stock went live on the exchange on the very last week at the value of 0.050 CAD; it closed at 0.100 CAD.

ME Therapeutics Holdings (METX) Stock Price in December 2023

ME Therapeutics Holdings started its trading journey in December 2023 with a whopping 710% growth in the share price in a week as the price closed at 0.81 CAD. In the remaining 3 weeks of December, the share price indeed grew, but no move was more than 20%.

ME Therapeutics Holdings (METX) Stock Price in January 2024

The first week of January was the first week in the history of the stock when the stock closed in red. In the 3rd week of January too, the stock closed in red, at the value of 1.02 CAD.

ME Therapeutics Holdings (METX) Stock Price in February 2024

In the four weeks of February, the stock grew at a phenomenal rate; the difference between the opening price in February and the highest price of February was more than 455%. In February, the closing price of CSE METX was 2.97 CAD.

ME Therapeutics Holdings (METX) Stock Price in March 2024

Much like February, in March too, there was not a single week when the stock closed in red. However, the growth of the stock was much less than what the stock grew in February. The opening and the closing price were 3.00 CAD and 3.41 CAD.

ME Therapeutics Holdings (METX) Stock Price in April 2024

The first three weeks of April for CSE METX were mostly flat, it was only the 4th week when the stock moved 5.11% up, and closed at 3.96 CAD for April.

ME Therapeutics Holdings (METX) Stock Price in May 2024

In the last week of May, the shares of ME Therapeutics Holdings grew by 24.06% to close at 4.95 CAD.

ME Therapeutics Holdings (METX) Stock Price in June 2024

From the month of June, the share price of METX began to crash. It crashed 25.05% in June as METX closed at 3.71 CAD for June 2024.

ME Therapeutics Holdings (METX) Stock Price in July 2024

Though in the first week the share price rose, in the other weeks it went down so much that the price was ultimately pulled down to 4.00 CAD from 4.90 CAD (July’s high).

ME Therapeutics Holdings (METX) Stock Price in August 2024

ME Therapeutics Holdings (METX) stock started with a positive price growth in August. In this month, the price went from 3.50 CAD in the opening of August to 3.85 CAD by the end of the first week of August. However, in the 2nd week, the price of METX collapsed by 22.08% and in the last week the price stood at 2.75 CAD, as the stock said farewell to August.

ME Therapeutics Holdings (METX) Stock Technical Analysis:

Chart and trend analysis:

ME Therapeutics Holdings (METX) latest trend on monthly as well as on weekly time frame is strongly negative.

Support and resistance analysis:

Around the level of 1.00 CAD, CSE METX has a strong support. However, there isn’t any strong resistance in the chart of the company as of now.

ME Therapeutics Holdings (METX) Stock Fundamental analysis:

Financial overview:

CSE METX has a market cap of 32.75M CAD. Though METX is free from debt as of now, the free cash flow figures don’t seem impressive, given their continuous downfall.

Company performance:

As a small-cap company, METX doesn’t generate any profit. It generated -495.99K CAD net loss in the last 3rd quarter of this year, the previous quarter the number was at -143.49K CAD.

Disclaimer

The stock price predictions provided are hypothetical and not financial advice. The author and blog are not responsible for any financial losses. Always consult with a financial advisor and do your own research before investing.

FAQ

What should be the share price target of ME Therapeutics Holdings for 2025?

For 2025, the target for METX will be 1.337 CAD/share.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top